US2015038535A1PendingUtilityA1

Thiophene-carboxamides useful as inhibitors of protein kinases

Assignee: VERTEX PHARMAPriority: May 23, 2006Filed: Sep 2, 2014Published: Feb 5, 2015
Est. expiryMay 23, 2026(expired)· nominal 20-yr term from priority
A61P 35/00A61P 43/00A61P 5/00A61P 37/08A61P 9/00A61P 35/02A61P 37/06A61P 25/28A61P 3/00A61P 29/00A61P 19/00A61P 11/06C07D 409/04
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.

Claims

exact text as granted — not AI-modified
1 . A compound of formula I: 
       
         
           
           
               
               
           
         
       
       wherein
 R 1  is H; 
 G is —O—; 
 L is C 0-3 alkyl optionally substituted with 0-3 J L ; 
 Ring A is 
 
       
         
           
           
               
               
           
         
       
       Ring A is optionally substituted with 0-3 J A ;
 Ring B is phenyl optionally substituted with 0-5 J B ; 
 Ring B′ is a 5-8 membered aromatic or nonaromatic monocyclic ring containing 0-3 heteroatoms selected from O, N, and S; Ring B′ is optionally substituted with 0-4 J B′ ; 
 each J A  and J B  is independently H, unsubstituted C 1-6 alkyl, halo, NO 2 , CN, OH, OR, SH, SR, NH 2 , NHR, N(R) 2 , COH, COR, CONH 2 , CONHR, CONR 2 , NHCOR, NRCOR, NHCONH 2 , NHCONHR, NHCON(R) 2 , SO 2 NH 2 , SO2NHR, SO2N(R) 2 , NHSO 2 R, or NRSO 2 R; 
 each J L  and J Z  is independently H, halo, unsubstituted C 1-6 alkyl NO 2 , CN, —NH 2 , —OH, or —CO 2 H; and 
 R is H. 
 
     
     
         2 - 11 . (canceled) 
     
     
         12 . The compound of  claim 1 , wherein J A  is H. 
     
     
         13 - 14 . (canceled) 
     
     
         15 . A compound having the following structure: 
       
         
           
           
               
               
           
         
       
     
     
         16 . A composition comprising a compound of any one of  claim 1 ,  12 , or  15 , and a pharmaceutically acceptable carrier, adjuvant, or vehicle. 
     
     
         17 - 33 . (canceled)

Join the waitlist — get patent alerts

Track US2015038535A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.